313 related articles for article (PubMed ID: 17384012)
21. [Amino-terminal pro-brain natriuretic peptide and brain natriuretic peptide measurements under various detection conditions in patients with chronic heart failure].
Wang WJ; Zhang XM; Wang Q; Wen DM; Ouyang NL; Cui YL; Li F
Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Aug; 39(8):695-9. PubMed ID: 22169413
[TBL] [Abstract][Full Text] [Related]
22. Different Susceptibility of B-Type Natriuretic Peptide (BNP) and BNP Precursor (proBNP) to Cleavage by Neprilysin: The N-Terminal Part Does Matter.
Semenov AG; Katrukha AG
Clin Chem; 2016 Apr; 62(4):617-22. PubMed ID: 26864319
[TBL] [Abstract][Full Text] [Related]
23. Head-to-head comparison of N-terminal pro-brain natriuretic peptide, brain natriuretic peptide and N-terminal pro-atrial natriuretic peptide in diagnosing left ventricular dysfunction.
Hammerer-Lercher A; Neubauer E; Müller S; Pachinger O; Puschendorf B; Mair J
Clin Chim Acta; 2001 Aug; 310(2):193-7. PubMed ID: 11498085
[TBL] [Abstract][Full Text] [Related]
24. Biomarker responses during and after treatment with nesiritide infusion in patients with decompensated chronic heart failure.
Miller WL; Hartman KA; Burritt MF; Borgeson DD; Burnett JC; Jaffe AS
Clin Chem; 2005 Mar; 51(3):569-77. PubMed ID: 15615816
[TBL] [Abstract][Full Text] [Related]
25. Biochemistry of B-type natriuretic peptide--where are we now?
Mair J
Clin Chem Lab Med; 2008; 46(11):1507-14. PubMed ID: 18842106
[TBL] [Abstract][Full Text] [Related]
26. Direct comparison of B-type natriuretic peptide (BNP) and amino-terminal proBNP in a large population of patients with chronic and symptomatic heart failure: the Valsartan Heart Failure (Val-HeFT) data.
Masson S; Latini R; Anand IS; Vago T; Angelici L; Barlera S; Missov ED; Clerico A; Tognoni G; Cohn JN;
Clin Chem; 2006 Aug; 52(8):1528-38. PubMed ID: 16777915
[TBL] [Abstract][Full Text] [Related]
27. Impact of renal disease on natriuretic peptide testing for diagnosing decompensated heart failure and predicting mortality.
deFilippi CR; Seliger SL; Maynard S; Christenson RH
Clin Chem; 2007 Aug; 53(8):1511-9. PubMed ID: 17586595
[TBL] [Abstract][Full Text] [Related]
28. Plasma NT-proBNP as a more reliable biomarker of endogenous cardiac natriuretic peptides than BNP during carperitide infusion.
Nishiyama K; Tsutamoto T; Tanaka T; Fujii M; Yamamoto T; Yamaji M; Horie M
Int Heart J; 2009 Mar; 50(2):183-90. PubMed ID: 19367029
[TBL] [Abstract][Full Text] [Related]
29. Comparison of the diagnostic accuracy of brain natriuretic peptide (BNP) and the N-terminal part of the propeptide of BNP immunoassays in chronic and acute heart failure: a systematic review.
Clerico A; Fontana M; Zyw L; Passino C; Emdin M
Clin Chem; 2007 May; 53(5):813-22. PubMed ID: 17384013
[TBL] [Abstract][Full Text] [Related]
30. Brain natriuretic peptide and N-terminal proBNP in chronic haemodialysis patients.
Racek J; Králová H; Trefil L; Rajdl D; Eiselt J
Nephron Clin Pract; 2006; 103(4):c162-72. PubMed ID: 16645318
[TBL] [Abstract][Full Text] [Related]
31. Midregional pro-atrial natriuretic peptide for the diagnosis of cardiac-related dyspnea according to renal function in the emergency department: a comparison with B-type natriuretic peptide (BNP) and N-terminal proBNP.
Chenevier-Gobeaux C; Guerin S; André S; Ray P; Cynober L; Gestin S; Pourriat JL; Claessens YE
Clin Chem; 2010 Nov; 56(11):1708-17. PubMed ID: 20813917
[TBL] [Abstract][Full Text] [Related]
32. Single assay for amino-terminal fragments of cardiac A- and B-type natriuretic peptides.
Ala-Kopsala M; Ruskoaho H; Leppäluoto J; Seres L; Skoumal R; Toth M; Horkay F; Vuolteenaho O
Clin Chem; 2005 Apr; 51(4):708-18. PubMed ID: 15718490
[TBL] [Abstract][Full Text] [Related]
33. Molecular heterogeneity has a major impact on the measurement of circulating N-terminal fragments of A- and B-type natriuretic peptides.
Ala-Kopsala M; Magga J; Peuhkurinen K; Leipälä J; Ruskoaho H; Leppäluoto J; Vuolteenaho O
Clin Chem; 2004 Sep; 50(9):1576-88. PubMed ID: 15265819
[TBL] [Abstract][Full Text] [Related]
34. Only large reductions in concentrations of natriuretic peptides (BNP and NT-proBNP) are associated with improved outcome in ambulatory patients with chronic heart failure.
Miller WL; Hartman KA; Grill DE; Burnett JC; Jaffe AS
Clin Chem; 2009 Jan; 55(1):78-84. PubMed ID: 19028821
[TBL] [Abstract][Full Text] [Related]
35. B-type natriuretic peptide and its molecular precursor in myocardial infarction complicated by cardiogenic shock.
Hejmdal A; Boesgaard S; Lindholm MG; Goetze JP
J Card Fail; 2007 Apr; 13(3):184-8. PubMed ID: 17448415
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic concordance between NT-proBNP and BNP for suspected heart failure.
Farnsworth CW; Bailey AL; Jaffe AS; Scott MG
Clin Biochem; 2018 Sep; 59():50-55. PubMed ID: 30111510
[TBL] [Abstract][Full Text] [Related]
37. Effect of compensated renal dysfunction on approved heart failure markers: direct comparison of brain natriuretic peptide (BNP) and N-terminal pro-BNP.
Luchner A; Hengstenberg C; Löwel H; Riegger GA; Schunkert H; Holmer S
Hypertension; 2005 Jul; 46(1):118-23. PubMed ID: 15939804
[TBL] [Abstract][Full Text] [Related]
38. Deconvolution analysis of cardiac natriuretic peptides during acute volume overload.
Pemberton CJ; Johnson ML; Yandle TG; Espiner EA
Hypertension; 2000 Sep; 36(3):355-9. PubMed ID: 10988264
[TBL] [Abstract][Full Text] [Related]
39. Analytical performances and heart failure research of the BNP and NT-proBNP assays on the Cobas E601 and ADVIA Centaur.
Zhang X; Wang W; Wang Q; Yang Y; Wen D; Yang Z; Lan H; Li F; Ouyang N; Kan L; Suo M; Yan H
Clin Lab; 2013; 59(7-8):715-25. PubMed ID: 24133898
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic accuracy of plasma brain natriuretic peptide and aminoterminal-proBNP in mild heart failure depends on assay and introduction of therapy.
Mikkelsen KV; Bie P; Møller JE; Ryde H; Videbaek L; Haghfelt T
Scand J Clin Lab Invest; 2005; 65(8):633-47. PubMed ID: 16319038
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
